Vismodegib as Eye-Sparing Adjuvant Treatment for Orbital Basal Cell Carcinoma
- 1 October 2013
- journal article
- case report
- Published by American Medical Association (AMA) in JAMA Ophthalmology
- Vol. 131 (10) , 1364-6
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Inhibiting the Hedgehog Pathway in Patients with the Basal-Cell Nevus SyndromeNew England Journal of Medicine, 2012
- Oral Hedgehog-Pathway Inhibitors for Basal-Cell CarcinomaNew England Journal of Medicine, 2012
- Efficacy and Safety of Vismodegib in Advanced Basal-Cell CarcinomaNew England Journal of Medicine, 2012
- Risk Factors for Orbital Exenteration in Periocular Basal Cell CarcinomaAmerican Journal of Ophthalmology, 2012
- Orbital Invasion by Periocular Basal Cell CarcinomaOphthalmology, 2005